OPEN NOW: CASPS – A Phase II Trial of Cediranib in the Treatment of Patients with Alveolar Soft Part Sarcoma
Sponsored by: The Institute of Cancer Research / The Royal Marsden NHS Foundation Trust
Information provided by: The Institute of Cancer Research – Clinical Trials and Statistics Unit
ClinicalTrials.gov Identifier: NCT01337401
Cediranib (AZD2171) is a new, unlicensed drug that has been studied in the laboratory and clinic, and researchers think it could slow the spread of ASPS. CASPS is a small clinical trial investigating cediranib in the treatment of ASPS, which is currently open to recruitment in the UK, Australia and Spain. Further information on CASPS and a list of hospitals involved in the trial can be found at http://cancerhelp.cancerresearchuk.org/trials/a-trial-cediranib-alveolar-soft-part-sarcoma-casps.
Objective: The aim of this study is to see if cediranib (AZD2171) can help people with alveolar soft part sarcoma.
With help of this miraculous medicine turning sexual activity order viagra usa into most pleasurable sexual experience would not be wrong in any way. As of now, we know that tadalafil without prescriptions is one of the most vital element of the body. Due to anti-inflammatory and immunomodulatory Shark Aid – dietary supplement with shark cartilage – may be recommended in price cialis drscoinc.com rheumatoid arthritis, osteoarthritis, rheumatism, osteoarticular trauma and autoimmune diseases. However, it is always good to buy generic viagra pills price drugs from reliable medical stores and prevent falling prey to illicit drug traders. Eligibility: Individuals 16 years of age and older who have been diagnosed with alveolar soft part sarcoma. Please note that other eligibility criteria do apply – for further details please go to http://cancerhelp.cancerresearchuk.org/trials/a-trial-cediranib-alveolar-soft-part-sarcoma-casps.
Contact: Professor Ian Judson: casps-icrctsu@icr.ac.uk
Locations: United Kingdom, Australia, Spain
______________________________________________________
Yosef Landesman, Ph.D.
President & Cancer Research Director
Cure Alveolar Soft Part Sarcoma International (iCureASPS)
e-mail: landesmany@yahoo.com